Splenectomy is not associated with a higher tricuspid regurgitant jet velocity in people with sickle cell anemia

Arpan A. Sinha, Tanvi Adusumilli, Hillel W. Cohen, Mehdi Nouraie, Jane Little, Deepa G. Manwani

Research output: Contribution to journalArticle

Abstract

Background: Vascular complications such as pulmonary hypertension (PH) occur at an increased rate following splenectomy in patients with various hemolytic blood disorders including thalassemia. The goal of this retrospective cross-sectional analysis was to assess the independent association of splenectomy with an elevated tricuspid regurgitation velocity (TRV) in people with homozygous sickle cell disease (HbSS). TRV is a noninvasive screening test for PH and a surrogate marker of prognosis in sickle cell disease (SCD). Procedure: Data were obtained from the multicenter Walk-PHaSST (treatment of pulmonary hypertension and sickle cell disease with sildenafil therapy) study of PH (NCT00492531). We compared TRV in the cohort of patients with HbSS who were surgically splenectomized with patients who were not surgically splenectomized. Results: We found no significant differences in TRV between the two groups. Conclusions: The lack of difference in TRV between the two groups is most likely because members of the comparator nonsurgical group in many cases experienced autoinfarction of the spleen in childhood. Splenectomy does not seem to confer additional risk for the development of a higher TRV in HbSS, unlike in patients with thalassemia or other hemolytic anemias. This could be an important consideration when weighing the risks and benefits of splenectomy in patients with HbSS.

Original languageEnglish (US)
Article numbere27928
JournalPediatric Blood and Cancer
DOIs
StatePublished - Jan 1 2019

Fingerprint

Tricuspid Valve Insufficiency
Sickle Cell Anemia
Splenectomy
Pulmonary Hypertension
Thalassemia
Hemolytic Anemia
Blood Vessels
Spleen
Cross-Sectional Studies
Biomarkers
Therapeutics

Keywords

  • PH
  • SCD
  • splenectomy
  • TRV

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Splenectomy is not associated with a higher tricuspid regurgitant jet velocity in people with sickle cell anemia. / Sinha, Arpan A.; Adusumilli, Tanvi; Cohen, Hillel W.; Nouraie, Mehdi; Little, Jane; Manwani, Deepa G.

In: Pediatric Blood and Cancer, 01.01.2019.

Research output: Contribution to journalArticle

@article{0db11b109bbf4b1abc0f9f1a789d4a68,
title = "Splenectomy is not associated with a higher tricuspid regurgitant jet velocity in people with sickle cell anemia",
abstract = "Background: Vascular complications such as pulmonary hypertension (PH) occur at an increased rate following splenectomy in patients with various hemolytic blood disorders including thalassemia. The goal of this retrospective cross-sectional analysis was to assess the independent association of splenectomy with an elevated tricuspid regurgitation velocity (TRV) in people with homozygous sickle cell disease (HbSS). TRV is a noninvasive screening test for PH and a surrogate marker of prognosis in sickle cell disease (SCD). Procedure: Data were obtained from the multicenter Walk-PHaSST (treatment of pulmonary hypertension and sickle cell disease with sildenafil therapy) study of PH (NCT00492531). We compared TRV in the cohort of patients with HbSS who were surgically splenectomized with patients who were not surgically splenectomized. Results: We found no significant differences in TRV between the two groups. Conclusions: The lack of difference in TRV between the two groups is most likely because members of the comparator nonsurgical group in many cases experienced autoinfarction of the spleen in childhood. Splenectomy does not seem to confer additional risk for the development of a higher TRV in HbSS, unlike in patients with thalassemia or other hemolytic anemias. This could be an important consideration when weighing the risks and benefits of splenectomy in patients with HbSS.",
keywords = "PH, SCD, splenectomy, TRV",
author = "Sinha, {Arpan A.} and Tanvi Adusumilli and Cohen, {Hillel W.} and Mehdi Nouraie and Jane Little and Manwani, {Deepa G.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/pbc.27928",
language = "English (US)",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Splenectomy is not associated with a higher tricuspid regurgitant jet velocity in people with sickle cell anemia

AU - Sinha, Arpan A.

AU - Adusumilli, Tanvi

AU - Cohen, Hillel W.

AU - Nouraie, Mehdi

AU - Little, Jane

AU - Manwani, Deepa G.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Vascular complications such as pulmonary hypertension (PH) occur at an increased rate following splenectomy in patients with various hemolytic blood disorders including thalassemia. The goal of this retrospective cross-sectional analysis was to assess the independent association of splenectomy with an elevated tricuspid regurgitation velocity (TRV) in people with homozygous sickle cell disease (HbSS). TRV is a noninvasive screening test for PH and a surrogate marker of prognosis in sickle cell disease (SCD). Procedure: Data were obtained from the multicenter Walk-PHaSST (treatment of pulmonary hypertension and sickle cell disease with sildenafil therapy) study of PH (NCT00492531). We compared TRV in the cohort of patients with HbSS who were surgically splenectomized with patients who were not surgically splenectomized. Results: We found no significant differences in TRV between the two groups. Conclusions: The lack of difference in TRV between the two groups is most likely because members of the comparator nonsurgical group in many cases experienced autoinfarction of the spleen in childhood. Splenectomy does not seem to confer additional risk for the development of a higher TRV in HbSS, unlike in patients with thalassemia or other hemolytic anemias. This could be an important consideration when weighing the risks and benefits of splenectomy in patients with HbSS.

AB - Background: Vascular complications such as pulmonary hypertension (PH) occur at an increased rate following splenectomy in patients with various hemolytic blood disorders including thalassemia. The goal of this retrospective cross-sectional analysis was to assess the independent association of splenectomy with an elevated tricuspid regurgitation velocity (TRV) in people with homozygous sickle cell disease (HbSS). TRV is a noninvasive screening test for PH and a surrogate marker of prognosis in sickle cell disease (SCD). Procedure: Data were obtained from the multicenter Walk-PHaSST (treatment of pulmonary hypertension and sickle cell disease with sildenafil therapy) study of PH (NCT00492531). We compared TRV in the cohort of patients with HbSS who were surgically splenectomized with patients who were not surgically splenectomized. Results: We found no significant differences in TRV between the two groups. Conclusions: The lack of difference in TRV between the two groups is most likely because members of the comparator nonsurgical group in many cases experienced autoinfarction of the spleen in childhood. Splenectomy does not seem to confer additional risk for the development of a higher TRV in HbSS, unlike in patients with thalassemia or other hemolytic anemias. This could be an important consideration when weighing the risks and benefits of splenectomy in patients with HbSS.

KW - PH

KW - SCD

KW - splenectomy

KW - TRV

UR - http://www.scopus.com/inward/record.url?scp=85069912181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069912181&partnerID=8YFLogxK

U2 - 10.1002/pbc.27928

DO - 10.1002/pbc.27928

M3 - Article

C2 - 31322833

AN - SCOPUS:85069912181

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

M1 - e27928

ER -